Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astra Indust | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 15.01B | 25.4x | 0.72 | SAR 187.80 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.4% Downside | Upgrade to Pro+ | |
Jamjoom Pharmaceuticals Factory | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 11.42B | 31.3x | 1.31 | SAR 162.60 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.8% Upside | Upgrade to Pro+ | |
Saudi chemical | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 8.82B | 27x | 0.15 | SAR 10.44 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SPIMACO | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 3.98B | 118.8x | 1.29 | SAR 33.10 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.4% Downside | Upgrade to Pro+ | |
Middle East Pharmaceutical | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 2.68B | 30x | 0.34 | SAR 133.40 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -7.9% Downside | Upgrade to Pro+ | |
Qomel | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 411.60M | 15.7x | 0.17 | SAR 116.60 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Almujtama Alraida Medical Co SJSC | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 290.70M | 26.2x | SAR 31 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |